Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 75382 · Class II · Central California Blood Center
Key facts
| Event ID | 75382 |
|---|---|
| Recall numbers | B-0124-2017 |
| Recalling firm | Central California Blood Center |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Red Blood Cells, collected from a donor who was allowed to donate without documentation regarding history of travel to a Zika endemic risk area, were distributed. |
| Initiation date | Aug 22, 2016 |
| Report date | Nov 9, 2016 |
| Termination date | Nov 3, 2016 |
| City | Fresno |
| State | CA |
| Country | United States |
| FEI number | 2970324 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: